AVXL Anavex Total Business Assets
Anavex Life Sciences (AVXL) focuses on developing treatments for dementia, where current R&D expenditures create a temporary financial gap prior to a potential surge in profitability. Management is concentrating on innovative CNS therapy methods. The stock price trend reflects total assets at 111.28. Business stability is guaranteed by a core team of leading neurology experts whose loyalty is maintained through a stock option system.
Analytical breakdowns and data insights for company Anavex Corp (AVXL)
- share price and consensus valuation forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Anavex Life Sciences|AVXL - Long-Term Debt to Equity|Current Liabilities to Capital Anavex Life Sciences Corp|AVXL - Company Aggregate Debts|Debts to Book Capitalization Anavex Life Sciences Corp|AVXL - Company Long-Term Debt|Company Short-Term Indebtedness Anavex Life Sciences|Quick Ratio anavex.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Anavex Life Sciences
For Anavex Life Sciences (AVXL), the trend in total assets reflects the resource base supporting costly clinical trials for CNS drugs. This metric, calculated inversely via ROA, measures the total value of assets and liabilities, allowing investors to monitor the R&D cash burn rate and promptly identify the risk of declining profitability resulting from balance sheet inflation.
Main competitors
BIIB (biogen.com) - Aggregate Company Assets|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|BHVN (Biohaven Ltd.) - Company Total Assets|Company Total Assets amylyx.com|Aggregate Company Assets Trevi Therapeutics, Inc. (TRVI)|Praxis Precision Medicines Inc - Total Business Assets|Company Total Assets CBLL (CeriBell Corp)|Company Total Assets Prothena PRTA|ALEC: Cumulative Company Assets|ANNX: Aggregate Company Assets|OMER: Company Total Assets|Company Assets Neurogene Inc (NGNE)|Cumulative Company Assets ACIU|Total Business Assets VYGR (Voyager Corp)|Cumulative Company Assets NMRA (Neumora Therapeutics)|SCLX (scilexholding.com) - Aggregate Asset Value|Aggregate Company Assets Tevogen Bio TVGN|Alpha Cognition Inc - Aggregate Company Assets|Cognition Therapeutics, Inc. - Company Total Assets|Company Total Asset Base Inhibikase Pharma IKT|SAVA: Company Total Assets|Total Asset Value of Company ASRT (Assertio)|COYA (Coya Therapeutics Inc) - Company Total Assets|Company Assets VistaGen Therapeutics Inc VTGN|Cumulative Company Assets OVID (Ovid Therapeutics Inc.)|ABOS (Acumen Pharmaceuticals, Inc) - Aggregate Asset Value|Aggregate Company Assets CervoMed Inc. CRVO|Company Total Asset Base Alterity Therapeutics Ltd. (ATHE)|Clene Nanomedicine - Company Total Assets|PepGen Inc. (PEPG) - Cumulative Company Assets|JUNS: Company Total Assets|RLMD - Company Total Asset Base|ANVS (Annovis Bio, Inc.) - Company Total Assets|Company Assets Grace Tx GRCE|Aggregate Company Assets Firefly Neuroscience (AIFF)|anewmeds.com - Total Business Assets|Company Total Assets NRSN (NeuroSense Therapeutics Ltd.)|RVPH - Cumulative Company Assets|MetaVia, Inc. - Company Total Assets|Company Assets neuraxis.com|heliusmedical.com (HSDT) - Aggregate Company Assets|PASG - Company Total Asset Base|NEUP (Neuphoria Therapeutics, Inc.) - Company Total Assets|Company Total Assets Minerva|Cumulative Company Assets ATHA (Athira Pharma, Inc.)|Aggregate Company Assets ADXN (addextherapeutics.com)|Alzamend Neuro - Cumulative Company Assets|CYCN: Total Business Assets|PTIX - Aggregate Company Assets|KTTA: Aggregate Company Assets|cortigent.com (CRGT) - Aggregate Company Assets|Total Business Assets ATXI|BCLI (BrainStorm Cell Therapeutics) - Company Total Assets|Company Assets Cara Therapeutics Inc. CARA|Cumulative Company Assets CHRO (Chromocell Therapeutics Corporation)|Company Total Assets eliemtx.com (ELYM)|Aggregate Company Assets Intra-Cellular Therapies, Inc. ITCI|Aggregate Asset Value LBPH|MRNS - Aggregate Company Assets|Company Assets NKGen Biotech Inc|NRBO: Company Total Assets|Sage Therapeutics Inc (SAGE) - Company Total Assets|Aggregate Company Assets Synaptogenix, Inc.|Total Business Assets TRVN (trevena.com)|Company Total Assets VIGL|Company Total Assets anewmeds.com (WENA)|Cerevel - Cumulative Company Assets